What Happens to Your Data and Samples

Part of Understanding Cancer Trials: Endings, and questions to take with you.

About 3 minutes. Free, in your language, no account needed.

This is general education about clinical research — not medical advice, and not a way to join a study. Talk to your own doctor about your situation.

Studies collect information about you, and cancer studies often collect physical samples too — blood, and sometimes tumor tissue.

Both deserve a clear explanation, and both are things you can ask about specifically.

How your information is usually handled

In most studies your records are coded. Your name and direct identifiers are replaced with a participant number, and the key linking the two is kept separately and securely at the hospital.

The sponsor and the people analyzing results generally see the coded information, not your name.

Some people do need access to your identifiable records: your study team, monitors checking that the study was run correctly, auditors, and regulatory inspectors. That access is part of how the integrity of research is verified, and it should be explained to you during consent rather than discovered later.

Data protection law applies as well, and differs by country. Your consent documents should say which law applies and what rights it gives you.

Samples

If the study collects blood or tissue, the questions are more specific than people often realize. Reasonable ones include:

• What samples are being taken, how much, and how often?
• Is an extra biopsy involved that would not otherwise be done?
• Are samples used only for this study, or stored for future research?
• If they are stored, for how long, and where — including whether they leave the country?
• Would future use be a new study with its own ethics approval?
• Can I take part in the study but decline the optional sample collection?
• Can I ask for stored samples to be destroyed later?

That last one has limits. Samples already used, or results already produced from them, generally cannot be undone.

Optional parts

Many cancer studies have optional sub-studies — additional samples, extra scans, genetic analyses, or questionnaires.

Optional means optional. You may take part in the main study and decline the extras, and this must not affect your participation or your care. If an "optional" part is presented as though it is expected, it is fair to ask directly whether it is required.

Genetic information

Some studies analyze genes in the tumor, and some analyze inherited genes.

These are different things with different consequences, and the difference is worth asking about. Inherited genetic findings can carry information about family members, and rules about whether such findings are returned to you differ by study and by country.

If any genetic analysis is involved, reasonable questions are: what is being analyzed, will I be told the results, what would happen if something unexpected but important were found, and who else could ever access it.

Withdrawal and data

As the previous module said: if you stop taking part, information already collected usually stays in the study, because removing it would distort results that have already been produced.

You can usually stop further collection. Whether stored samples can be destroyed on request depends on the study and the law where you are, and should be stated in your consent documents.

In short

• Study information about you is usually coded, with the key to your identity kept separately and securely.
• Some people, including monitors, auditors and inspectors, may see identifiable records to verify the study was run properly.
• Ask what samples are taken, whether they are stored, for how long, where, and whether future use needs new ethics approval.
• Optional sub-studies are genuinely optional and declining them must not affect your care.
• Genetic analysis of a tumor and of inherited genes are different things, with different consequences for you and your family.